Rigel Pharma (RIGL) Tops Q4 EPS by 2c, Tops on Revenue
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $46.64 --0%
EPS Growth %: -34.9%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -34.9%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $35.8 million versus the consensus estimate of $34.1 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- CLSA Reiterates Outperform (2) Rating on CSL Ltd. (CSL:AU) (CMXHF)
- Citi lowers East West Bancorp price target to $152
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
